Associated Papers
POR polymorphisms are associated with 21 hydroxylase deficiency.
Pecori Giraldi F et al.
Journal of Endocrinological Investigation, 2021
P450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms.
Burkhard FZ et al.
The Journal of Steroid Biochemistry and Molecular Biology, 2017
Pharmacogenomics of human P450 oxidoreductase.
Pandey AV et al.
Frontiers in Pharmacology, 2014
Genetic polymorphisms and haplotypes of por, encoding cytochrome p450 oxidoreductase, in a Japanese population.
Saito Y et al.
Drug Metabolism and Pharmacokinetics, 2011
Clinical and biochemical consequences of p450 oxidoreductase deficiency.
Flück CE et al.
Endocrine Development, 2011
Genetic variation in human P450 oxidoreductase.
Miller WL et al.
Molecular and Cellular Endocrinology, 2009
Pharmacogenetics of P450 oxidoreductase: effect of sequence variants on activities of CYP1A2 and CYP2C19.
Agrawal V et al.
Pharmacogenetics and Genomics, 2008
P450 oxidoreductase: genetic polymorphisms and implications for drug metabolism and toxicity.
Hart SN et al.
Expert Opinion on Drug Metabolism & Toxicology, 2008
Genetics of P450 oxidoreductase: sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations.
Huang N et al.
Proceedings of the National Academy of Sciences of the United States of America, 2008
P450 oxidoreductase deficiency - a new form of congenital adrenal hyperplasia.
Flück CE et al.
Endocrine Development, 2008
Select a paper to view details